Features of the course of manifest forms of acute hepatitis C

Abstract

Aim. To identify clinical, epidemiological and laboratory-instrumental features of acute hepatitis C at the present stage according to the infectious hospital data.

Methods. The study included 111 patients with acute hepatitis C aged from 18 to 79 years who were hospitalized in Republican Clinical Infectious Diseases Hospital named after A.F. Agafonov in 2011 - I quarter of 2017. Acute hepatitis C was diagnosed in accordance with the guidelines of the Ministry of Health of the Russian Federation.

Results. In the study group, females aged 21 to 40 years, non-working, predominantly living in Kazan with medical transmission of infection (34 %) prevailed. The disease was mild and moderately severe (71 %). The icteric form was observed in 94 % of patients, in 3.6 % - with a cholestatic component. When comparing laboratory parameters, markers of cytolysis and cholestasis differed significantly in patients depending on the severity (p<0.001). Changes in the gallbladder walls (an ultrasound marker of cholestasis) were revealed in 21.4 % of patients. On specific examination, the viral RNA was detected in 100 % of patients. Analysis of serological markers revealed predominance of antibodies to core and NS3 proteins, M class antibodies were detected only in half of the patients. Specific antibodies were absent (“dark diagnostic window”) in 3 % of patients with mild and 6 % of moderate form of the disease.

Conclusion. The feature of the course of acute viral hepatitis C was the predominance of moderate forms (71 %) with medical transmission of infection. Icteric forms of acute viral hepatitis C were diagnosed in 94 % of patients (in 3.6 % cases with the development of cholestatic component). PCR is a mandatory method of specific diagnosis of acute viral hepatitis C, and in case of a “dark diagnostic window” becomes the leading method.

Keywords

acute hepatitis C / clinical picture / diagnosis

References

[1] Enaleeva D.Sh., Fazylov V.Kh., Sozinov A.S. Khronicheskie virusnye gepatity V, S i D. Rukovodstvo dlya vrachey. (Chronic viral hepatitides B, C, and D. Handbook for physicians.) Moscow. 2011; 464 p. (In Russ.)

[2] Еналеева Д.Ш., Фазылов В.Х., Созинов А.С. Хронические вирусные гепатиты В, С и D. Руководство для врачей. М.: МЕДпресс-информ; 2011; 464 с.

[3] Pimenov N.N., Chulanov V.P., Komarova S.V. et al. Hepatitis C in Russia: epidemiological characteristics and ways to improve diagnosis and surveillance. Epidemiologiya i infektsionnye bolezni. 2012; 3: 4–10. (In Russ.)

[4] Пименов Н.Н., Чуланов В.П., Комарова С.В. и др. Гепатит С в России: эпидемиологическая характеристика и пути совершенствования диагностики и надзора. Эпидемиология и инфекционные болезни. 2012; 3: 4-10.

[5] Косаговская И.И., Волчкова Е.В. Медико-социальные аспекты вирусных гепатитов с парентеральным путем передачи. Эпидемиология и инфекционные болезни. 2013; 1: 28–39. [Kosagovskaya I.I., Volchkova E.V. Medico-social aspects of viral hepatitis with parenteral transmission. Epidemiologiya i infektsionnye bolezni. 2013; 1: 28–39.

[6] Косаговская И.И., Волчкова Е.В. Медико-социальные аспекты вирусных гепатитов с парентеральным путем передачи. Эпидемиология и инфекционные болезни. 2013; 1: 28-39.

[7] (In Russ.)]

[8] Ющук Н.Д., Климова Е.А., Знойко О.О. и др. Вирусные гепатиты. Клиника, диагностика, лечение. М.: ГЭОТАР-Медиа. 2014: 85-114.

[9] Yushchuk N.D., Klimova E.A., Znoyko O.O. et al. Virusnye gepatity. Klinika, diagnostika, lechenie. (Viral hepatitis. Clinic, diagnosis, treatment.) Moscow: GEOTAR-Media. 2014: 85–114. (In Russ.)

[10] Быстрова Т.Н., Михайлова Ю.В. Молекулярно-генетическая характеристика вируса гепатита С. МедиАль. 2014; 12 (2): 88-102.

[11] Bystrova T.N., Mikhaylova Yu.V. Molecular-genetic characteristics of the hepatitis C virus. MediAl’. 2014; 12 (2): 88–102. (In Russ.)

[12] Трифонова Г.Ф., Левакова И.А., Болсун Д.Д., Мукомолов С.Л. Острый и хронический гепатит С в Российской Федерации в 1994-2013 гг. Инфекция и иммунитет. 2014; 4 (3): 267-274. DOI:10.15789/2220-7619-2014-3-267-274.

[13] Trifonova G.F., Levakova I.A., Bolsun D.D., Mukomolov S.L. Acute and chronic hepatitis C in the Russian Federation in 1994–2013. Infektsiya i immunitet. 2014; 4 (3): 267–274. (In Russ.)

[14] Рекомендации по диагностике и лечению взрослых больных гепатитом С. https://arvt.ru/sites/default/files/rf-recom-gep-C-2014.pdf, https://arvt.ru/sites/default/files/iia-hcv-2017.pdf (дата обращения 15.03.18).

[15] Recommendations for the diagnosis and treatment of the adult patients with hepatitis C. https://arvt.ru/sites/default/files/rf-recom-gep-C-2014.pdf,https://arvt.ru/sites/default/files/iia-hcv-2017.pdf (Access date: 15.03.18). (In Russ.)

[16] Еналеева Д.Ш., Бешимова Д.Т. Зависимость активности аланинаминотрансферазы от пола пациента при вирусных гепатитах В. Казанский мед. ж. 2012; 93 (3): 456-457.

[17] Enaleeva D.Sh., Beshimova D.T. The dependence of the activity of alanine aminotransferase on the gender o the patient in viral hepatitis B. Kazanskiy meditsinskiy zhurnal. 2012; 93 (3): 456–457. (In Russ.)

[18] Мухин Н.А. Справочник по гепатологии. М.: Литера. 2009; 399 с.

[19] Mukhin N.A. Spravochnik po gepatologii. (Handbook of hepatology.) Moscow: Litera. 2009; 399 р. (In Russ.)

[20] Фазылов В.Х., Фазульзянова А.И., Баширова Д.К., Хаертынова И.М., Подряднова Т.В. Способ диагностики развития холестаза при острых вирусных гепатитах. Патент на изобретение РФ № 2159080. Бюлл. от 20.11.2000.

[21] Fazylov V.Kh., Fazul'zyanova A.I., Bashirova D.K., Khaertynova I.M., Podryadnova T.V. Diagnostics of the cholestase syndrome in patients with chronic hepatitis C. Patent for invention RF No 2159080. Bull. issued on 20.11.2000. (In Russ.)

RIGHTS & PERMISSIONS

Fazylov V.K., Fazulzyanova A.I., Tkacheva S.V., Mukhamerdieva Z.T., Zheglova A.A., Rezyapova I.I., Rezyapova A.I.